Literature DB >> 10475102

Analysis of brain proteins in Alzheimer's disease using high-resolution two-dimensional gel electrophoresis.

T Tsuji1, S Shimohama, S Kamiya, T Sazuka, O Ohara.   

Abstract

Two-dimensional gel electrophoresis (2-DE), a method which can be used to analyze the expression of many proteins, is a promising and powerful approach which we have begun to use in the characterization of the complex pathologic processes in Alzheimer's disease (AD). In the present study, a reliable 2-DE database of human brain proteins was created by improving the reproducibility of 2-DE images using an immobilized pH gradient (IPG) for the first dimension gel electrophoresis and Melanie II as the program for data analysis. The brain samples were taken from the temporal cortex of brains at autopsy from 15 AD patients and 15 age-matched controls with non-neurological disorders. About 700 spots were located as consistently expressed proteins in the human brain, all of which were expressed also in AD brains. Comparing the density of spots between AD and normal control, we found that five protein spots were significantly increased, 28 spots were significantly decreased and nine spots were detected only in AD. Two spots among those significantly increased and one spot among those significantly decreased were identified as glial fibrillary acidic proteins. The database of brain proteins in AD constructed for the present study, including the statistical data of density changes in AD, should be a useful beginning for a comprehensive human 2-DE database available via the Internet, which will facilitate further investigation of pathogenic protein alterations in AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475102     DOI: 10.1016/s0022-510x(99)00120-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Proteomic approach for the elucidation of biological defects in autism.

Authors:  M A Junaid; R K Pullarkat
Journal:  J Autism Dev Disord       Date:  2001-12

2.  Proteomic profiling and neurodegeneration in Alzheimer's disease.

Authors:  T Tsuji; A Shiozaki; R Kohno; K Yoshizato; S Shimohama
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Proteomic approach to probe for larval proteins of the mussel Mytilus galloprovincialis.

Authors:  José Luis López; Silvia Lorenzo Abalde; José Fuentes
Journal:  Mar Biotechnol (NY)       Date:  2005-06-04       Impact factor: 3.619

4.  The role of phenotypic plasticity on the proteome differences between two sympatric marine snail ecotypes adapted to distinct micro-habitats.

Authors:  Mónica Martínez-Fernández; María Páez de la Cadena; Emilio Rolán-Alvarez
Journal:  BMC Evol Biol       Date:  2010-03-08       Impact factor: 3.260

5.  Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.

Authors:  Yair M Gozal; Duc M Duong; Marla Gearing; Dongmei Cheng; John J Hanfelt; Christopher Funderburk; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

6.  Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer.

Authors:  Afroz S Mohammad; Chris E Adkins; Neal Shah; Rawaa Aljammal; Jessica I G Griffith; Rachel M Tallman; Katherine L Jarrell; Paul R Lockman
Journal:  BMC Cancer       Date:  2018-12-07       Impact factor: 4.430

7.  Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization.

Authors:  Cristina M Pedrero-Prieto; Alicia Flores-Cuadrado; Daniel Saiz-Sánchez; Isabel Úbeda-Bañón; Javier Frontiñán-Rubio; Francisco J Alcaín; Lourdes Mateos-Hernández; José de la Fuente; Mario Durán-Prado; Margarita Villar; Alino Martínez-Marcos; Juan R Peinado
Journal:  Alzheimers Res Ther       Date:  2019-06-29       Impact factor: 6.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.